Merck Sues Watson Labs To Block Generic Contraceptive

Law360, New York (June 5, 2013, 1:14 PM EDT) -- Merck & Cie and Bayer Pharma AG on Tuesday accused generic-drug maker Watson Laboratories Inc. of infringing the patent for their contraceptive Safyral by seeking approval for a generic version of the drug, according to identical suits filed in federal courts in Delaware and Nevada.

Switzerland-based Merck, which owns the patent for Safyral, and Bayer, the patent's exclusive licensee, asked the court for a permanent injunction barring Watson from manufacturing or selling its generic and preventing the U.S. Food and Drug Administration from approving it before...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.